# Mark M. Awad

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-m-awad/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,840 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 87 |
| i10-index | 226 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5086249998 |
| ORCID iD | https://orcid.org/0000-0003-0928-5244 |
| Works | 1,492 |

## Researcher papers

Showing 12 of 17.

- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer](https://scholariq.org/papers/the-alk-inhibitor-ceritinib-overcomes-crizotinib-resistance-in-non-small-cell/)
- [Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors](https://scholariq.org/papers/genomic-correlates-of-response-to-immune-checkpoint-blockade-in-microsatellite/)
- [<i>MET</i> Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent <i>MET</i> Genomic Amplification and c-Met Overexpression](https://scholariq.org/papers/i-met-i-exon-14-mutations-in-non-small-cell-lung-cancer-are-associated-with/)
- [STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment](https://scholariq.org/papers/stk11-lkb1-deficiency-promotes-neutrophil-recruitment-and-proinflammatory/)
- [PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course](https://scholariq.org/papers/pd-1-inhibitor-related-pneumonitis-in-advanced-cancer-patients-radiographic/)
- [Perioperative Nivolumab in Resectable Lung Cancer](https://scholariq.org/papers/perioperative-nivolumab-in-resectable-lung-cancer/)
- [Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway](https://scholariq.org/papers/treatment-induced-tumor-dormancy-through-yap-mediated-transcriptional/)
- [False-Positive Plasma Genotyping Due to Clonal Hematopoiesis](https://scholariq.org/papers/false-positive-plasma-genotyping-due-to-clonal-hematopoiesis/)
- [Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels](https://scholariq.org/papers/association-of-high-tumor-mutation-burden-in-non-small-cell-lung-cancers-with/)
- [Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status](https://scholariq.org/papers/diminished-efficacy-of-programmed-death-ligand-1-inhibition-in-stk11-and-keap1/)
- [EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer](https://scholariq.org/papers/egfr-mutation-subtypes-and-response-to-immune-checkpoint-blockade-treatment-in/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.